ICU, hospital and one year mortality of patients suffering from solid or haematological malignancies
OBJECTIVE: To examine the demographics, evolution and outcome of patients suffering from malignancies admitted to a medical intensive care unit.
PATIENTS AND METHODS: Single centre retrospective cohort study of patients with malignancies. Data on demographics, diagnosis laboratory tests, provided therapy and outcome were retrospectively collected. Data was analysed for differences between patients suffering from solid compared to haematological malignancies as well as for predictors of one year survival.
RESULTS: A total of 74 consecutive patients with a median age of 62 years were enrolled. From these, 42 (57%) suffered from solid and 32 (43%) from haematological malignancies. In total, 64% of patients with solid malignancies presented with metastatic disease. The main reason for intensive care unit admission in patients with solid malignancies was acute cardiovascular failure (39%) and infections in patients with haematological malignancies (38%). Intensive care unit mortality, hospital mortality and one year mortality were 26%, 35% and 71% overall; 17%, 29% and 69% respectively in patients with solid and 38%, 44% and 73% respectively in patients with haematological malignancies. Survival was close to 40% in patients with no or one organ failure. Survival dropped to 20% with 2 and 13% with ≥3 organs in failure. The number of organs in failure predicted hospital fatality with an AUCRoc of 0.87.
CONCLUSION: The number of failing organs rather than malignancy itself drives outcome even in patients with malignancies. Thus the number of organs in failure rather than diagnosis should guide intensive care unit management in patients with malignancies.
- Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 1999;160:1957–61.
- Groeger JS, Lemeshow S, Price K, Nierman DM, White P, Jr., Klar J, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model. J Clin Oncol. 1998;16:761–70.
- Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28:1322–8.
- Maschmeyer G, Bertschat FL, Moesta KT, Hausler E, Held TK, Nolte M, et al. Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer. 2003;39:783–92.
- Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33:520–6.
- Evison J, Rickenbacher P, Ritz R, Gratwohl A, Haberthur C, Elsasser S, et al. Intensive care unit admission in patients with haematological disease: Incidence, outcome and prognostic factors. Swiss Med Wkly. 2001;131:681–6.
- Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002;28:1294–300.
- Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med. 2006;32:93–9.
- Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA. 1993;269:783–6.
- Groeger JS, White P, Jr., Nierman DM, Glassman J, Shi W, Horak D, et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol. 1999;17:991–7.
- Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA. Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med. 1996;44:254–60.
- Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med. 2000;28:1014–7.
- Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: A case for restricted use. Bone Marrow Transplant. 1993;12:501–7.
- Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998;158:876–84.
- Soubani AO, Kseibi E, Bander JJ, Klein JL, Khanchandani G, Ahmed HP, Guzman JA. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical icu. Chest. 2004;126:1604–11.
- Khassawneh BY, White P, Jr., Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121:185–8.
- Bach PB, Schrag D, Nierman DM, Horak D, White P, Jr., Young JW, et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood. 2001;98:3234–40.
- Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E, et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory icu. Eur Respir J. 1998;12:116–22.
- Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24:643–9.
- Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med. 2001;29:519–25.
- Ferra C, Marcos P, Misis M, Morgades M, Bordeje ML, Oriol A, et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: A single-center experience. Int J Hematol. 2007;85:195–202.
- Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33:2488–93.
- Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (saps ii) based on a european/north american multicenter study. JAMA. 1993;270:2957–63.
- Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, et al. The use of maximum sofa score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the esicm. Intensive Care Med. 1999;25:686–96.
- Moreno R, Vincent JL, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The sofa (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med. 1996;22:707–10.
- Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the sofa score to predict outcome in critically ill patients. JAMA. 2001;286:1754–8.
- Buchheidt D, Hummel M, Engelich G, Hehlmann R. Management of infections in critically ill neutropenic cancer patients. J Crit Care. 2004;19:165–73.
- Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V, et al. Outcome of cancer patients considered for intensive care unit admission: A hospital-wide prospective study. J Clin Oncol. 2005;23:4406–13.
- den Boer S, de Keizer NF, de Jonge E. Performance of prognostic models in critically ill cancer patients – a review. Crit Care. 2005;9:R458–63.
- Lamia B, Hellot MF, Girault C, Tamion F, Dachraoui F, Lenain P, et al. Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the icu. Intensive Care Med. 2006;32:1560–8.
- Merz TM, Schar P, Buhlmann M, Takala J, Rothen HU. Resource use and outcome in critically ill patients with hematological malignancy: A retrospective cohort study. Crit Care. 2008;12:R75.
- Soares M, Carvalho MS, Salluh JI, Ferreira CG, Luiz RR, Rocco JR, et al. Effect of age on survival of critically ill patients with cancer. Crit Care Med. 2006;34:715–21.
- Silfvast T, Pettila V, Ihalainen A, Elonen E. Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand. 2003;47:301–6.
- Sculier JP, Paesmans M, Markiewicz E, Berghmans T. Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med. 2000;28:2786–92.
- Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, et al. Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med. 2000;26:1817–23.
- Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures. Eur J Cancer. 1997;33:1031–7.